Senores Pharmaceuticals enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
6,098——
18.045.6105
28.630.926.1
327327305
6,436——
309282199
₹1,397.63——
1,3591,2921,117
24.1%25.3%27.3%
0.05×——
8.91×——
30.23×——
36.66×——
Reference items — trailing FY values
722633398
21316889.7
17613772.9
—62.1−45.9
−178−178−203
—−184−207
—240158
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SENORES₹1,324.30

Senores Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersSANOFIINNOVACAPMOREPENLABIOLCPFDCPGHLSANOFICONRORCHPHARMAMcap ₹6,098 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——6,098.4
- Cash, Equiv & ST Investments105.445.618.0
+ Minority Interest26.130.928.6
+ Total Debt304.8327.1327.1
Enterprise Value——6,436.1
Net Debt (memo)199.4281.5309.1
EV per Share——1,397.63
Total Capital1,117.01,291.61,358.6
Total Debt/Total Capital27.2825.3224.08
Total Debt/EV——0.05
EV/Sales——8.91
EV/EBITDA——30.23
EV/EBIT——36.66
Reference Items — Trailing FY Values
Sales398.3632.6722.3
EBITDA89.7168.3212.9
EBIT72.9137.1175.6
Operating Cash Flow-45.962.1—
Free Cash Flow-203.4-178.1-178.1
FCFF (free cash flow to the firm)-207.0-183.8—
Capital Expenditure157.5240.1—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.